Skip to content

CASE STUDY 05 / 06

Ketoconazole–PABA cocrystal

Martin et al., Molecular Pharmaceutics 2020, 17, 919–932

10×

INCREASE IN AQUEOUS SOLUBILITY REPORTED IN THE STUDY

Challenge

Low aqueous solubility can limit the development potential of certain pharmaceutical compounds.

Scientific approach

The published research prepared and characterized a 1:1 ketoconazole–p-aminobenzoic acid cocrystal and investigated its physical and pharmacological properties.

Published findings

The study reported a tenfold increase in aqueous solubility and a 6.7-fold improvement in oral bioavailability in the reported experimental model; its safety findings require context and should not be generalized to clinical use.

Development relevance

Crystal engineering can modify material properties; development relevance must be assessed for each molecule and intended product.

Source

Martin et al., Molecular Pharmaceutics 2020, 17, 919–932; DOI 10.1021/acs.molpharmaceut.9b01178.

View publication(opens in a new tab)
RELATED SERVICEPreformulation & Specialized Development

Discuss Your Challenge